As part of this partnership, Huma and AstraZeneca will launch Software as a Medical Device (SaMD) companion apps targeted at several therapeutic areas and will partner to help accelerate the adoption of decentralized clinical trials
Enables millions of Indians to monitor their vitals without the need of any additional device
It will showcase the company’s latest technologies in robotics, digital health and orthopaedic implants
Direct to consumer pharmacy and formation as pharmacy benefit manager further mission to drastically expand access to affordable pharmaceuticals
The transaction improves patient experience, patient outcomes and aims to reduce health care costs
Subscribe To Our Newsletter & Stay Updated
